Brief: Aadi Bioscience Reports Q4 Loss Per Share Of $0.52

Whitehawk Therapeutics

28/03/2023 13:41

March 28 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH
QUARTER AND FULL-YEAR 2022 AND PROVIDES CORPORATE UPDATE
    * AADI BIOSCIENCE INC - QTRLY LOSS PER SHARE $0.52

Source text for Eikon:  ID:nPnbS8r9Ga 
Further company coverage:  AADI.O 

 ((Reuters.Briefs@thomsonreuters.com;))